Impax Asks To Appeal Budeprion MDL Dismissal Bid
Impax Laboratories Inc., mired in multidistrict litigation over its generic antidepressant Budeprion XL, has asked a court to let it appeal its refusal to dismiss the case, challenging the judge's reliance...To view the full article, register now.
Already a subscriber? Click here to view full article